Fresenius Group is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany. The company provides system-critical products and services for therapies serving critically and chronically ill patients. It operates across Europe, the Americas, and other global markets, employing around 176,000 people (excluding Fresenius Medical Care). In the 2024 financial year, the group reported annual revenue of €21.5 billion.
The group's operations span three main business segments. Fresenius Kabi supplies products for critically and chronically ill patients, working in areas including (bio)pharma, clinical nutrition, and medical technology. Fresenius Helios is Europe's leading private hospital operator. Fresenius Medical Care, a separately listed entity, is the world's leading provider of dialysis products and services, serving approximately 4.5 million patients.
With more than 100 years of heritage, the company is focused on delivering affordable, accessible, and innovative healthcare products and high-quality clinical care. The group's technical domains cover biopharmaceuticals, medical technology, and care provision across its operating segments.